Catalyst Wire Dossier Catalyst Wire Dossier

Calcipotriene foam 0.005%

calcipotriene · Mayne Pharma International Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Calcipotriene foam 0.005%, covering 2019-01-22 to 2019-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis [Phase 1]

See pricing